Skip to content

Cooley 2 Vascular Prosthesis Straight

by Meadox Medicals, Div. Boston Scientific Corp.

510(k) K812248

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK812248 Date24 Nov 1981ClearedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 22 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
DSY
Device Class
Class II
Regulation
21 CFR Part 870.3450
Advisory Committee
Cardiovascular
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 19 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Cooley 2 Vascular Prosthesis Straight is a vascular graft prosthesis designed for use in cardiovascular procedures. It is classified as a Prosthesis, Vascular Graft, of 6mm and greater diameter, intended for surgical implantation to replace or bypass damaged blood vessels.

This device is supplied sterile and intended for single-use. It is regulated under FDA 510(k) clearance (K812248) and falls under the Cardiovascular Device classification. The prosthesis is manufactured by Meadox Medicals, now part of Boston Scientific Corp., and is intended for use in controlled surgical settings where vascular reconstruction is required.

Other devices from Meadox Medicals, Div. Boston Scientific Corp.

See all devices from Meadox Medicals, Div. Boston Scientific Corp. →

Questions

AI-generated answers, 19 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What types of cardiovascular procedures is the Cooley 2 Vascular Prosthesis Straight intended for, and how is it used in those procedures?

    The Cooley 2 Vascular Prosthesis Straight is designed for surgical implantation to replace or bypass damaged blood vessels with a diameter of 6mm or greater. It is intended for use in vascular reconstruction procedures, such as bypass surgeries or direct vessel replacements, where a durable synthetic graft is required to restore blood flow. The prosthesis is sewn into place during surgery to create a new pathway for blood circulation, ensuring continuity where natural vessels are compromised.

  • Is the Cooley 2 Vascular Prosthesis Straight intended for reuse, or is it meant to be used only once?

    The Cooley 2 Vascular Prosthesis Straight is explicitly intended for single-use only. This design ensures patient safety by preventing cross-contamination and maintaining sterility, which is critical in surgical settings where infection control is paramount.

  • How is the Cooley 2 Vascular Prosthesis Straight supplied, and what should I consider when storing it?

    The device is supplied sterile, ready for immediate use in controlled surgical environments. Since it is single-use, it should be stored in its original packaging in a clean, dry place away from direct sunlight or extreme temperatures. Proper storage ensures the graft remains uncontaminated and maintains its structural integrity until use.

  • What regulatory pathway does the Cooley 2 Vascular Prosthesis Straight follow, and how does this affect its use?

    The Cooley 2 Vascular Prosthesis Straight is regulated under the FDA’s 510(k) clearance process, specifically classified as a Prosthesis, Vascular Graft, of 6mm and greater diameter. It was granted clearance in 1981 under the traditional review pathway and is categorized under the Cardiovascular Device classification. This means it has undergone FDA evaluation to ensure safety and effectiveness for its intended surgical use in vascular reconstruction.